Form 4 for STRO SUTRO BIOPHARMA, INC.
Accepted 2021-09-28 00:00:00 ET · period of report 2021-09-24 · accession 0001209191-21-057977 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-28 | 2021-09-24 | STRO | FITZPATRICK LINDA A | Chief People, Comm. Off | F - Tax | $19.23 | -2,619 | 25.7K | -9% | -$50.4K |
| D | 2021-09-28 | 2021-09-24 | STRO | FITZPATRICK LINDA A | Chief People, Comm. Off | M - OptEx | $0.00 | +7,576 | 28.3K | +37% | $0 |
| D | 2021-09-28 | 2021-09-24 | STRO | FITZPATRICK LINDA A | Chief People, Comm. Off | M - OptEx | $0.00 | -7,576 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-24 | F | D | 2,619 | $19.23 | 25,676 | D | — | — | (F1) Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. |
| 2 | Common | Common Stock | 2021-09-24 | M | A | 7,576 | $0.00 | 28,295 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit (RSU) | 2021-09-24 | M | D | 7,576 | $0.00 | 0 | D | — · — to 2021-09-26 | 7,576 Common Stock | (F3) Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. (F4) The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. |